RecruitingNCT05232032
How a brain receptor blocker affects decision-making in depression and anxiety research
About this title
Read the official source — NCT05232032Medication studyAges 18–45United States
Understand this study
Who could participate?
Listed age limits: 18 years to 45 years.
- Listed locations
- BelmontSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 112
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT05232032
- Official title
Show the full official title
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Nociceptin Receptor Antagonist.
Who can participate?
Listed age limits: 18 years to 45 years.
Is this study still recruiting?
The registry lists this study as recruiting.
